RFS Failed as Endpoint in Adjuvant Immunotherapy Trials ...Middle East

A new analysis found that relapse-free survival is a poor surrogate endpoint for overall survival in adjuvant immunotherapy trials in a variety of cancer types. Medscape Medical News

Hence then, the article about rfs failed as endpoint in adjuvant immunotherapy trials was published today ( Monday 31/07/2023 - 04:17 PM ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( RFS Failed as Endpoint in Adjuvant Immunotherapy Trials )

Also on site :

• Disgraced former Centinela Valley schools Superintendent Jose Fernandez dies
• Tyler Perry Sued for Sexual Assault By New Accuser, an Actor in a ‘Madea’ Movie
• New law revives dormant plans for solar plant near Mojave National Preserve